Form 4: DocuSign CFO Sells Shares Following RSU Vesting
SEC Form 4 Filing
DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold shares of the company's stock following the vesting of restricted stock units.
Summary
- DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, engaged in multiple transactions involving the company's stock.
- On December 15, 2024, 51,401 shares were acquired through the vesting of restricted stock units (RSUs).
- Also on December 15, 2024, 20,227 shares were withheld to cover tax obligations related to the RSU vesting.
- On December 16, 2024, 5,135 shares were sold at an average price of $94.42.
- Additionally, on December 16, 2024, 2,865 shares were sold at an average price of $95.41.
- The CFO also acquired 23,141 RSUs on December 15, 2024, which vest over time.
- Another 23,141 RSUs were acquired on December 15, 2024, with a different vesting schedule.
- Finally, 5,119 RSUs were acquired on December 15, 2024, with a different vesting schedule.
Sentiment
Score: 5
Explanation: The document reflects routine insider transactions, which are neither particularly positive nor negative. The sales are likely part of normal financial planning for the executive.
Negatives
- The CFO sold a total of 8,000 shares on December 16, 2024, which could be interpreted as a lack of confidence in the company's short-term prospects.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.
- The vesting schedules of the RSUs could lead to further sales in the future.
Industry Context
This filing is a routine disclosure of insider transactions and is common for executives who receive stock-based compensation. It does not necessarily indicate a change in the company's outlook or performance.
Comparison to Industry Standards
- Executive stock sales are a common occurrence in publicly traded companies, particularly after vesting periods for equity compensation.
- The sale of shares by the CFO is not unusual and is often part of personal financial planning.
- The vesting schedules of the RSUs are typical for technology companies, with vesting occurring over several years to incentivize long-term performance.
Stakeholder Impact
- The stock sales could have a minor negative impact on shareholder sentiment, but this is likely to be temporary.
- The transactions do not directly impact employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 12/15/2024 | Date of RSU vesting and tax withholding, as well as acquisition of additional RSUs. |
| 12/16/2024 | Date of stock sales by the CFO. |
| 12/17/2024 | Date of filing of the Form 4. |
| 06/10/2023 | Vesting commencement date for some of the RSUs. |
| 09/10/2024 | Vesting date for 25% of some of the RSUs. |
| 05/10/2024 | Vesting commencement date for some of the RSUs. |
| 06/10/2025 | Final vesting date for some of the RSUs. |
Keywords
DocuSign, DOCU, insider trading, Form 4, Blake Jeffrey Grayson, CFO, restricted stock units, RSU, stock sale, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.